RYARX
Price
$19.54
Change
+$0.11 (+0.57%)
Updated
Jan 31 closing price
Net Assets
32.94M
RYUHX
Price
$19.57
Change
+$0.11 (+0.57%)
Updated
Jan 31 closing price
Net Assets
32.94M
Ad is loading...

RYARX vs RYUHX

Header iconRYARX vs RYUHX Comparison
Open Charts RYARX vs RYUHXBanner chart's image
Rydex Inverse S&P 500® Strategy A
Price$19.54
Change+$0.11 (+0.57%)
VolumeN/A
Net Assets32.94M
Rydex Inverse S&P 500® Strategy H
Price$19.57
Change+$0.11 (+0.57%)
VolumeN/A
Net Assets32.94M
RYARX vs RYUHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYARX vs. RYUHX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYARX is a Hold and RYUHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYARX (32.9M) and RYUHX (32.9M) have equal amount of cash in the bank . RYARX (3.32) and RYUHX (3.32) have matching dividends . RYARX was incepted earlier than RYUHX: RYARX (21 years) vs RYUHX (10 years). RYARX (2500) and RYUHX (2500) have matching initial minimum investment requirements. RYUHX (-14.41) and RYARX (-14.43) have marching annual gain over last year. RYUHX (-52.03) and RYARX (-52.11) have equivalent 5 years return.
RYARXRYUHXRYARX / RYUHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years10 years-
Gain YTD-2.203-2.200100%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRA1000N/A-
Net Assets32.9M32.9M100%
Annual Yield % from dividends3.323.32100%
Returns for 1 year-14.43-14.41100%
Returns for 3 years-19.25-19.17100%
Returns for 5 years-52.11-52.03100%
Returns for 10 years-73.83-73.81100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUGDF25.151.34
+5.63%
Lundin Gold Inc.
CIHKY28.130.44
+1.59%
China Merchants Bank Co., Ltd.
BZLFY21.480.31
+1.46%
Bunzl plc
MRAAY8.06-0.04
-0.49%
Murata Manufacturing Inc.
PVCT0.11N/A
-3.17%
Provectus Biopharmaceuticals, Inc.